Trial Profile
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2017
Price :
$35
*
At a glance
- Drugs RIX 4414 (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- 17 May 2017 Planned number of patients changed from 4550 to 10210.
- 01 Apr 2017 Results published in the PLOS Medicine
- 27 Jun 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.